Professor Toshihide Tsuda's Press Conference on "Pediatric Thyroid Cancer After the Fukushima Accident"


Below is the press conference presentation (in Japanese with English interpretation) given by Professor Toshihide Tsuda of Okayama University at the Foreign Correspondence Club of Japan (FCCJ) on October 8, 2015 (Japan time). 

On October 6, 2015, an epidemiological analysis of Fukushima thyroid cancer data by Professor Tsuda's research group was published online ahead of print in Epidemiology, official journal of the International Society for Environmental Epidemiology. The main author of the study, Professor Tsuda is an environmental epidemiologist who has devoted himself to clarifying the cause of health effects in numerous environmental cases such as Minamata disease, Nishi-Yodogawa air pollution in Osaka, and recognition of lung cancer in pneumoconiosis patients as an occupational disease. 


Here's the announcement of the press conference on the FCCJ website:


Thursday, October 08, 2015, 15:00 - 16:00
"Pediatric Thyroid Cancer after the Fukushima Accident" 
Toshihide Tsuda
Professor, Graduate School of 
Environmental and Life Science, Okayama University
Language: The speech and Q & A will be in Japanese with English interpretation

 Almost five years after the triple meltdown at the Fukushima Daiichi nuclear power plant, attention is turning to the possible long-term health effects radiation exposure has had on local people, particularly children.

 A large-scale thyroid ultrasound screening examination is underway in Fukushima Prefecture, covering about 370,000 children who were 18 or younger at the time of the accident.

 Despite evidence of much higher rates of juvenile thyroid cancer in the prefecture compared with the pre-accident incidence rate, local medical authorities and the central government claim that the Fukushima disaster is not the cause.

 They point to the evacuation of tens of thousands of people in the immediate aftermath, and the ban on the sale of locally produced milk and other produce. The authorities, 
backed by prominent international experts, claim the increased rate of thyroid cancer is due to the highly sensitive ultrasound equipment being used to test Fukushima children.

 But in a significant challenge to that thesis, Toshihide Tsuda, professor of environmental epidemiology at Okayama University, believes the excess occurrence of juvenile thyroid cancer is not due merely to the screening effect, but is the consequence of exposure to radiation.

 Tsuda, whose study appears in this month's Epidemiology, the journal of the International Society of Environmental Epidemiology, will come to the Club on 8 October to explain his findings and take questions.

 An expert in epidemiology and environmental medicine, Tsuda has devoted much of his career to the study of health and environmental pollution cases, including Minamata disease, air pollution in Nishi-Yodogawa, Osaka, and the recognition of lung cancer in pneumoconiosis patients as an occupational disease.

The official FCCJ video of the press conference is embedded below:
 


Below is the English version of the press conference presentation prepared ahead of time for distribution to participants. 
It is posted here with Professor Tsuda's permission.  Professor Tsuda did not necessarily adhere to these contents, however. Watching the video above is strongly encouraged as he explains his analysis in a clear manner, adding more background information and giving a mini lecture with power point presentation. English interpretation is of high quality, making the video highly informative. (In the video he talks about the Japanese government's lobbying effort to influence the draft version of the WHO dose estimation report. That information can be seen here).

 1. Overview of the paper    

Thyroid screening examination was started in all Fukushima residents age 18 or younger in October 2011 after the March 2011 Tokyo Electric Fukushima Daiichi nuclear power plant accident following the Great East Japan Earthquake and Tsunami. The first round screening (Initial Screening) conducted during FY 2011 through FY 2013 was completed, and the second round screening (Full-Scale Screening) is underway in FY 2014 and FY 2015. Ever since February 2013, the examination results have been released to the public, in Japanese as well as English, on the Fukushima Prefecture website. However, no epidemiological analysis has been carried out on the released data, leading to extremely insufficient conditions for causal inference, public health and clinical policy planning, future outlook and information disclosure to residents.
   The Okayama University team used standard epidemiological methods to analyze released data, and submitted the results as an original article to Epidemiology, official journal of the International Society of Environmental Epidemiology. I would like to report here that the article has been accepted and published online ahead-of-print.

【Original article】(PDF here)
Thyroid Cancer Detection by Ultrasound among Residents Aged 18 Years and Younger in Fukushima, Japan: 2011 to 2014
http://journals.lww.com/epidem/Abstract/publishahead/Thyroid_Cancer_Detection_by_Ultrasound_Among.99115.aspx

Toshihide Tsuda1, Akiko Tokinobu2, Eiji Yamamoto3, Tatsuji Suzuki2

1Department of Human Ecology, Graduate School of Environmental and Life Science, Okayama University; 2Department of Epidemiology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University; 3Department of Information Science, Faculty of Informatics, Okayama University

Abstract

Background: After the Great East Japan Earthquake and Tsunami in March 2011, radioactive elements were released from the Fukushima Daiichi Nuclear Power Plant. Based on prior knowledge, concern emerged about a consequential increased incidence of thyroid cancer among exposed residents.

Methods: After the release, Fukushima Prefecture performed ultrasound thyroid screening on all residents aged ≤18 years. The first round of screening included 298,577 examinees (as of December 31, 2014), and a second round began in April 2014. We analyzed the prefecture results from the first and second round up to December 31, 2014, in comparison with the Japanese annual incidence and the incidence within Fukushima Prefecture.

Results: The highest incidence rate ratio, using a latent period of 4 years, was observed in the Central Middle District of the prefecture compared with the Japanese annual incidence (incidence rate ratio = 50; 95% confidence interval: 25, 90). The prevalence of thyroid cancer was 605 per million examinees (95% CI: 302, 1,082) and the prevalence odds ratio compared with the reference district in Fukushima Prefecture was 2.6 (95% CI: 0.99, 7.0). In the second screening round, even under the assumption that the rest of examinees were disease-free, an incidence rate ratio of 12 has already been observed (95% CI: 5.1, 23).

Conclusions: An excess of thyroid cancer has been detected by ultrasound among children and adolescents in Fukushima Prefecture within 4 years of the release, and is unlikely to be explained by a screening surge.


2. Significance of publication of the paper and the issue of screening effect and the overdiagnosis discourse 

   This analysis revealed that thyroid cancer incidence within three years of the accident increased by several tens of times in Fukushima residents who were age 18 or younger at the time of the accident in comparison to the Japanese annual incidence, and that it would be impossible to attribute the increase to reasons other than radiation, such as the screening effect or overdiagnosis. According to discussions by some specialists, screening effect refers to detection of so-called “true cancer” 2-3 years earlier than it would be diagnosed clinically. Overdiagnosis  refers to detection due to screening of so-called “false cancer,” or a mass of cancer cells, which may never be clinically diagnosed as cancer in life. In many of the ongoing discussions, these two — screening effect and overdiagnosis — are collectively called “screening effect,” with its meaning mainly referring to the definition of “overdiagnosis” stated above.
   Our analysis reveals that the thyroid cancer incidence at the end of 2014 far exceeds the 15-year thyroid cancer risk estimated in the WHO Health risk assessment from the nuclear accident after the 2011 Great East Japan earthquake and tsunami released in late February 2013. Moreover, while a tendency towards excess occurrence of thyroid cancer was beginning to be observed in Chernobyl in 1987 — the year after the accident, this analysis actually showed ultrasound screening allowed detection of an increased incidence of thyroid cancer within one year.
   I will now explain why the screening effect and overdiagnosis are not valid explanations for excess detection of thyroid cancer cases. First, the thyroid cancer incidence rate calculated in our analysis is 20-50 times the pre-accident rate. This is an order of magnitude higher than the increased incidence in thyroid cancer due to causes other than radiation exposure reported in the past. The effect generally called “screening effect” results in the incidence rate about several times higher than the pre-screening rate in cancers including thyroid cancer. It is impossible to explain the increased incidence this high by causes other than radiation.
   Next, despite repeated statements that there is no precedence of mass screening and follow-ups in populations with little exposure such as Initial Screening in Fukushima, studies have been published on the results of ultrasound screening in Chernobyl conducted in children and adolescents who were conceived and born post-accident or who lived in areas with relatively low levels of contamination. A total of 47,203 underwent screening, with not a single case of thyroid cancer detected. Although the age range slightly differs from screening in Fukushima Prefecture, this result cannot be explained by differences in the level of sophistication of ultrasound equipment in detecting 5 mm nodules.


*1: Demidchik YE et al. : Childhood thyroid cancer in Belarus, Russia and Ukraine after Chernobyl and at present. 
   Arq Bras Endocrinol Metab 2007; 51: 748-762.
*2: Shibata Y et al: 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 2001; 358: 1956-1966.
*3: Ito M et al: Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology. Thyroid 1995; 5(5): 365-368.

   Moreover, geographical variations in cancer detection rates (prevalence rates) within Fukushima Prefecture cannot be explained by the screening effect or overdiagnosis. Also, the emerging results of the second round screening point to the increased incidence rate which is already about 20 times higher than the pre-accident rate even under the assumption of large underestimation. When data released on August 31, 2015 are analyzed by areas and districts, it becomes apparent incidence rates in some areas and districts are beginning to exceed the first round incidence rates. As cases detected due to screening effect and overdiagnosis should have been harvested (harvesting effect), it is suggested the effect of radiation exposure due to the accident is beginning to appear within Fukushima Prefecture.
   In addition to overdiagnosis, a claim of overtreatment is often made. However, the post-surgical data of thyroid cancer cases operated at Fukushima Medical University, shows there is no evidence that premature or excessive surgeries were conducted, with the exception of 3 cases where patients and/or their families opted for voluntary surgery despite an option of non-surgical observational follow-up. Rather, the data suggests the fast progression of cancer in the operated cases. I am going to introduce an excerpt of the document titled, “Regarding Surgically Indicated Cases,” released by Professor Shinichi Suzuki of Fukushima Medical University.

Regarding Surgically Indicated Cases (see here for the complete translation of the original version)

“As of March 31, 2015, 104 among those eligible for thyroid examination underwent surgery after being diagnosed to have “malignant or suspicious” tumors in the confirmatory examination. 97 cases were operated on at the Division of Thyroid and Endocrine Surgery, Fukushima Medical University and 7 at other facilities. As 1 of 97 cases turned out to be a benign nodule post-operatively, 96 thyroid cancer cases are discussed here. According to the pathological evaluation, 93 cases were papillary thyroid cancer and 3 were poorly differentiated thyroid cancer. (…) The post-surgical pathological diagnosis revealed 28 cases (29%) with tumor diameter ≤ 10 mm, excluding 14 cases with mild extrathyroidal extension. And 8 cases (8%) had no lymph node metastasis, extrathyroidal extension, or distant metastasis (pT1a pN0 M0). Of all 96 cases, mild extrathyroidal extension (pEX1) was seen in 38 cases (39%), and lymph node metastasis was positive in 72 cases (74%). “  



3. Perspectives and reactions of international epidemiologists

   Starting with the WHO Health risk assessment, the majority of experts expected an increase in thyroid cancer incidence in Fukushima Prefecture after the accident. As a result, there was no strong opposition to the results of our analysis. We have analyzed newly released data and presented the results at the annual conferences of the International Society for Environmental Epidemiology (ISEE) in Basel in 2013, Seattle in 2014, and San Paulo in 2015. Our presentation drew a big interest, and the results of our analysis have been accepted without any issues other than astonishment about how high the rate is. This reaction made us feel that there is a large gap between the international expert opinions and the explanation of screening effect and overdiagnosis in Japan.


4. Recommendations as a public health specialist

   So far, hardly any radiation protection measures have been discussed other than evacuation in Fukushima Prefecture. Therefore, many recommendations can be presented given the results of our analysis. There is no reason not to prepare for the increased incidence at a full pace anticipated beyond 5 years after the accident or other expected situations. At present time, administrative bodies should urgently establish and implement countermeasures, including media relations, rather than discussing whether thyroid cancer cases have actually increased or not, or their causal relationship with radiation exposure.
   First, in preparation for the potential increase in thyroid cancer cases after the fourth post-accident year, medical resources should be checked to ensure that they are fully equipped. It appears that Fukushima Medical University owns a medical robotic system — the daVinci surgical system — which is supposed to eliminate visible scars of thyroid surgery. Its use should be considered even though it is not covered by the national health insurance.
   Next, an attempt should be made to keep track of thyroid cancer cases in an expansive  and well-developed manner, including cases in Fukushima residents 19 or older at the time of the accident or cases outside Fukushima Prefecture.
   Furthermore, the current assessment of thyroid cancer cases relies only on ultrasound screening. As time goes on, participation is likely to decline. A medical record booklet system such as the Hibakusha booklet should be established and the cancer registry should be well-developed in cooperation with prefectural and municipal medical associations.
   In addition, we need to prepare for and begin assessment and investigation of cancer other than thyroid cancer, such as leukemia, breast cancer and other solid cancers which are expected to increase according to the WHO Health Risk Assessment. Minimum latency period for blood-borne malignant neoplasms such as leukemia has already passed. Also, I believe it is necessary to investigate non-cancer illnesses and prepare to deal with them.
   Of course, it is necessary to gather further evidence to conduct a more detailed analysis of incidence data of thyroid cancer and other illnesses in Chernobyl. Also, dose estimation for radioactive iodine should be reconsidered due to an excess occurrence of thyroid cancer beyond the estimation by WHO.
   Naturally, the resettlement plan to return evacuees to areas with an air dose rate of 20 mSv/year should be postponed for the time being. If the resettlement plan is based on a scientifically incorrect statement, “Radiation-induced cancer does not occur, or is undetectable even if it occurs, under the exposure dose of 100 mSv,” then that’s all the more reason for the plan to be halted and reconsidered.
   As the air dose rate is still quite high, a more meticulous plan by age should be urgently prepared, although this has hardly been discussed in the past. In other words, further radiation protection measures should ideally be planned and implemented, including temporary evacuation plans for pregnant women, infants, toddlers, children, adolescents, and women with pregnancy potential, in that order.
   Lastly, I would like to discuss explanations consistently given in Fukushima Prefecture such as, “Cancer incidence will not increase due to the Fukushima nuclear accident” or “Even if cancer incidence increases, it will not be detectable.” These statements are only validated if both of the following two conditions hold true: 1) There is no (excess) occurrence of radiation-induced cancers below the exposure dose of 100 mSv; 2) Exposure dose in Fukushima Prefecture never exceeded 100 mSv, and all the exposure doses were much below 100 mSv. These two conditions have prevented most of discussions regarding realistic and cost-conscious radiation protection measures.
   But condition 1 is not even scientifically accurate, and no experts inside or outside Japan will make such a statement nowadays. And condition 2 is not accurate since the thyroid equivalent dose was estimated to exceed 100 mSv in residents outside the 20 km zone according to the WHO Preliminary dose estimation report released in 2012, which became the basis of the 2013 WHO Health risk assessment report. Our analysis showed results which appear to far exceed the 15-year thyroid cancer risk in the WHO Health risk assessment.
   However, it has only been four and a half years since the nuclear accident. Considering the average latency period for thyroid cancer and the time trend of excess occurrence of thyroid cancer in Chernobyl, it is highly likely that new thyroid cancer cases might appear every year at a 10 to 20 times higher rate than the last four and a half years. Under such a circumstance, a swift correction of statements by the government is needed: otherwise, trust will be lost, resulting in disruption to responses and measures to the reality. I hope our study will provide an opportunity to review announcements and response plans of the government. Current situations will only worsen anxiety, mistrust, and damages due to baseless rumors.
  



Science of SAMRAI (Or Politics?)


On the September 21, 2015 issue of the New York Times, a science writer George Johnson published an article, "When Radiation Isn’t the Real Risk," which starts with the following phrase: 
     "This spring, four years after the nuclear accident at Fukushima, a small group of scientists met in Tokyo to evaluate the deadly aftermath."

No details are given by George Johnson as to who these scientists are except for Mohan Doss, a medical physicist. It is not clear if this was intentional. Below is some background information on this meeting and the rest of its participants, followed by some interesting facts relating to the potential political ties and the stance (or the lack of stance) of radiation hormesis model in radiation protection. (Note: This post focused on presenting facts on selective aspects of Johnson's ill-written article).


*****

SAMRAI 2014 and SARI

The meeting by “a small group of scientists” referred to by Johnson's RAW DATA article in the September 21, 2015 issue of the New York Times is SAMRAI 2014 sponsored by the Society for Radiation Information and the Legislators' Committee for the Study of the Effects of Radiation. The acronym “SAMRAI” stands for the Scientific Advisory Meeting for Radiation and Accurate Information. This document describes the background and aim of SAMRAI 2014, a joint effort of the Society for Radiation Information and the Scientists for Accurate Radiation Information (SARI), with a strong wish for the recovery of the 20 km zone of the Fukushima Daiichi nuclear power plant. According to this SARI post, Society of Radiation Information is essentially SARI's Japanese counterpart.

SAMRAI 2014 met in Tokyo on March 24, 2015. Here's the programPresenters included the following five individuals:

June Takada: Professor, Sapporo Medical University; program chair, SAMRAI 2014

Wade Allison: Emeritus Professor of Physics, Oxford University; SARI member
Mohan Doss:  Medical physicist in diagnostic imaging; Associate Professor, Fox Chase Cancer Center; SARI member
Sadao Hattori: Former honorary special advisor at the Central Research Institute for Electric Power Industry (CRIEPI).
Hironobu Nakamura: Radiologist and hormesis advocate, former Professor at Osaka University

Their abstracts are included in this documentRecommendations by SAMRAI 2014 to the Japanese government include return of evacuees to the 20 km zone. 

SAMRAI 2014 was originally scheduled to be held at the Lower House Diet Members’ First Office Building on December 3, 2014 (thus the name SAMRAI 2014 rather than SAMRAI 2015), followed by a press conference by Wade Allison. However, the November 21, 2014 dissolution of the Lower House and subsequent general election necessitated postponement of SAMRAI 2014 as the Lower House Diet Members' First Office Building was unavailable during the election period. Nevertheless, Allison's press conference proceeded as scheduled at the Foreign Correspondence Club of Japan on December 3, 2014.




Potential Political Ties

Further investigation reveals an interesting fact: executive members of the Society for Radiation Information overlap with the membership of a revisionist organization, Society for the Dissemination of Historical Fact.

Society for Radiation Information: executive members
Chairman: Shoichi Watanabe
Vice chairman: Hideaki Kase
Vice chairman: Hironobu Nakamura 
Board member: Sadao Hattori
Board member: Jun Takada 
Board member/secretary: Hiromichi Moteki 

Advisors include members of the Legislators’ Committee for the Study of the Effects of Radiation. The first four listed below also belong to a revisionist, right-wing organization, Nippon Kaigi.

Society for Radiation Information: advisors
Takeo Hiranuma 
Yoshitaka Sakurada 
Hirofumi Ryu 
Hiroshi Yamada 
Yuzuru Nishida 


Radiation Hormesis Model in Radiation Protection

As mentioned in Johnson's article, SARI members submitted petitions to the Nuclear Regulatory Commission to adopt the radiation hormesis model instead of the linear no-threshold (LNT) model in radiation protection. (Public comments are accepted until November 19, 2015). 

In 1989, Sadao Hattori, a SAMRAI 2014 presenter, was chair of the Hormesis Study Group established at CRIEPI (Central Research Institute for Electric Power Industry), a research center for the Japanese electric power industry. It is not clear when Hattori left CRIEPI. 
Interestingly, in June 2014, CRIEPI released an official statement refuting the use of radiation hormesis in radiation protection, stating:
  • Currently our center is not conducting research on radiation hormesis.
  • Based on the knowledge gained so far, we consider it difficult to generalize the effects of hormesis as the low-dose radiation effects and to incorporate them into the radiation risk assessment.
  • There are some instances where merchandise with hormesis effects are sold with reference to our research results, but our center has nothing to do with it.

  • From the 1990s to the early 2000s, our center conducted studies to verify the effects of radiation hormesis. We elucidated that various hormesis-like effects were induced by low-dose radiation in animal experiments under certain conditions. However, at this time, we consider it difficult to generalize the effects of hormesis as the low-dose radiation effects and incorporate them into the radiation risk assessment mainly for the following two reasons.

    First, many of the radiation hormesis effect verification experiments use animals not in healthy conditions (animals born prone to illnesses or animals with cancer cells transplanted). A special series of experiments like these are used to improve observation of the radiation response since the low-dose radiation effects are extremely difficult to detect. We consider it inappropriate to estimate effects in healthy human from the results obtained from such experiments.


    Second, verification experiments of the radiation hormesis effects limit indices which are being observed. For instance, in research on diseases caused by reactive oxygen, indices related to reactive oxygen are studied: whereas in most cases, indices considered as issues related to general radiation effects, such as lifetime cancer incidence or lifespan changes, are not studied. As the effects of radiation are multifaceted, we believe they should not be determined only by one-sided data.  


    Please keep the above points in mind when viewing past research results of the radiation hormesis effects currently listed on our website. 


    Furthermore, although we consider it difficult to apply the low-dose radiation hormesis effects towards the radiation risk assessment of the public, this does not mean we flatly deny their application to medical fields. However, please beware that our center has nothing to do sales of merchandise claiming radiation hormesis effects based on the results of our research (we will never cooperate with sales activities of specific products).
*****

Lastly, another interesting set of information Johnson might have been unaware of is a series of exchanges, shown as urls below, between SARI members and the authors of the Swiss study, “Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study.”

http://ehp.niehs.nih.gov/1509938/
http://ehp.niehs.nih.gov/1509938R/
http://ehp.niehs.nih.gov/1510111/
http://ehp.niehs.nih.gov/1510111R/

The final paragraph in the second response by the authors, shown in the fourth link, sums it up:
     "It seems to us that the 'Scientists for Accurate Radiation Information' a priori exclude the possibility that low-dose radiation could increase the risk of cancer. They will therefore not accept studies that challenge their foregone conclusion."




Research Center for Japanese Electric Power Industry Refutes Application of Radiation Hormesis in Radiation Protection


Below is a translation of the June 13, 2014 statement by the Central Research Institute of Electric Power Industry (CRIEPI).


Our Opinions on Radiation Hormesis Effects
June 13, 2014

Radiation Safety Research Center
Nuclear Technology Research Laboratory
Central Research Institute of Electric Power Industry 


  • Currently our center is not conducting research on radiation hormesis.
  • Based on the knowledge gained so far, we consider it difficult to generalize the effects of hormesis as the low-dose radiation effects and to incorporate them into the radiation risk assessment.
  • There are some instances where merchandise with hormesis effects are sold with reference to our research results, but our center has nothing to do with it.


From the 1990s to the early 2000s, our center conducted studies to verify the effects of radiation hormesis. We elucidated that various hormesis-like effects were induced by low-dose radiation in animal experiments under certain conditions. However, at this time, we consider it difficult to generalize the effects of hormesis as the low-dose radiation effects and incorporate them into the radiation risk assessment mainly for the following two reasons.

First, many of the radiation hormesis effect verification experiments use animals not in healthy conditions (animals born prone to illnesses or animals with cancer cells transplanted). A special series of experiments like these are used to improve observation of the radiation response since the low-dose radiation effects are extremely difficult to detect. We consider it inappropriate to estimate effects in healthy human from the results obtained from such experiments.

Second, verification experiments of the radiation hormesis effects limit indices which are being observed. For instance, in research on diseases caused by reactive oxygen, indices related to reactive oxygen are studied: whereas in most cases, indices considered as issues related to general radiation effects, such as lifetime cancer incidence or lifespan changes, are not studied. As the effects of radiation are multifaceted, we believe they should not be determined only by one-sided data.  

Please keep the above points in mind when viewing past research results of the radiation hormesis effects currently listed on our website. 

Furthermore, although we consider it difficult to apply the low-dose radiation hormesis effects towards the radiation risk assessment of the public, this does not mean we flatly deny their application to medical fields. However, please beware that our center has nothing to do sales of merchandise claiming radiation hormesis effects based on the results of our research (we will never cooperate with sales activities of specific products).

Surgical and Pathological Details of Fukushima Thyroid Cancer Cases Released on August 31, 2015


Below is an English translation of the information released by Fukushima Medical University at the August 31, 2015 meeting of the 20th Oversight Committee for the Fukushima Health Management Survey. It includes surgical and pathological details of the 96 thyroid cancer cases operated on at Fukushima Medical University as of March 31, 2015. (See this post for an English translation of the previous version released on November 11, 2014).

These 96 cancer cases, along with one case post-surgically diagnosed to be a benign nodule and 7 cases operated on at other medical facilities, comprise the 104 cases (99 from the first round and 5 from the second round screening) that had undergone surgeries as of the 19th Oversight Committee Meeting for the Fukushima Health Management Survey held on May 19, 2015. This information is essentially the most updated details of the surgical cases since only one more surgical case (papillary thyroid cancer; age and tumor size unknown) was added as of June 30, 2015 (probably due to the new school year starting in April in Japan), according to the information released at the most recent Oversight Committee meeting held on August 31, 2015. 


***



August 31, 2015

Regarding Surgically Indicated Cases


Shinichi Suzuki, M.D., Ph.D.
Chair, Division of Thyroid and Endocrine Surgery
Fukushima Medical University Hospital


As of March 31, 2015, 104 among those eligible for thyroid examination underwent surgery after being diagnosed to have “malignant or suspicious” tumors in the confirmatory examination. 97 cases were operated on at the Division of Thyroid and Endocrine Surgery, Fukushima Medical University and 7 at other facilities. As 1 of 97 cases turned out to be a benign nodule post-operatively, 96 thyroid cancer cases are discussed here. According to the pathological evaluation, 93 cases were papillary thyroid cancer and 3 were poorly differentiated thyroid cancer.

In the pre-operative diagnosis, tumor diameter was > 10 mm in 63 cases (66%) and and ≤10 mm in 33 (34%). Also, of 33 cases with tumor diameter ≤10 mm, lymph node metastasis, mild extrathyroidal extension, or distant metastasis were suspected in 8 (8%), not suspected (cT1acN0cM0) in 25 (25%). Of these 25 cases, 22 were suspected to be close to the trachea or the recurrent laryngeal nerve, or have mild extracapsular extension. The remaining 3 cases were operated on according to patients’ wishes, despite the recommendation of non-surgical follow-up observation.

Furthermore, 23 (24%) cases were positive for lymph node metastasis, and 2 cases (2%) were suspected of distant metastasis — multiple lung metastasis.

Surgical methods included total thyroidectomy in 6 cases (6%), and hemithyroidectomy in 90 cases (94%). Lymph node dissection was conducted in all cases, with 80% limited to the central compartment and 20% including lateral compartment. As much as possible, small-size incisions of 3 cm were used.

The post-surgical pathological diagnosis revealed 28 cases (29%) with tumor diameter ≤ 10 mm, excluding 14 cases with mild extrathyroidal extension. And 8 cases (8%) had no lymph node metastasis, extrathyroidal extension, or distant metastasis (pT1a pN0 M0). 

Of all 96 cases, mild extrathyroidal extension (pEX1) was seen in 38 cases (39%), and lymph node metastasis was positive in 72 cases (74%). No post-operative complications (post-surgical hemorrhage, permanent paralysis of recurrent laryngeal nerve, hypoparathyroidism, or hypothyroidism after hemithyoidectomy) were observed.

Due to a small number of pediatric thyroid cancer cases [in general], a strict comparison is not yet possible. However, in general, juvenile thyroid cancers are characterized by good prognosis despite a higher rate of lymph node metastasis, if appropriately treated. Pediatric thyroid cancers with pre-operative findings of large lymph node metastasis, marked extra thyroidal extension (EX2) and distant metastasis are considered to belong to a high risk group, and total thyroidectomy is recommended even when the cancer is localized to one side of the thyroid gland. However, when lymph node metastasis and mild extrathyroidal extension are not apparent pre-operatively but found in the post-operative pathological diagnosis for the first time, these findings are considered unrelated to the prognosis. Therefore, every case with these findings [i.e. post-surgical lymph node metastasis and mild extrathyroidal extension] does not necessarily have poor prognosis, but it is unclear if the prognosis would still be good without surgery, and these findings do not offer proof of unnecessary surgery. These discussions need to be carried out carefully, and we intend to follow the development of the examination further. Removal of the entire thyroid gland necessitates a continual use of the thyroid hormone medication, but removal of only one half of the thyroid gland preserves the thyroid function from the remaining half, making the thyroid hormone medication unnecessary and allowing patients to lead daily lives just as they did before surgery. Therefore, at FMU we perform hemithyroidectomy unless the case is clearly high risk, in an effort to maintain the quality of life (QOL) of the patients.


Fukushima Thyroid Examination May 2024: 276 Surgically Confirmed as Thyroid Cancer Among 330 Cytology Suspected Cases

  Note: From this post onward, the terms "Age 25+ Survey" and "Age 30+ Survey" are to replace "Age 25 Milestone Scr...